Skip to content
value.today
RenovoRx, Inc. logo

RenovoRx, Inc.

🇺🇸 San Jose, California, USAHealth CareFounded 2012
Total raised
$12 M
3 rounds on record
Latest round
$8 M
Apr 2018
First round on record
Dec 2013
Today
Went public
See the company page

RenovoRx, Inc. is listed today as RenovoRx, Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.

Funding rounds of RenovoRx, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2026$10 MPrivate placement after listing$10 to $50 million

RenovoRx, Inc.: Private sale, Mar 2026

Investors in this round

16 investors had bought by the notice of Apr 9, 2026: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$10,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
$549,996
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Leesa R. Gentry · Executive Officer
  • Mark R. Voll · Executive Officer
  • Ramtin R. Agah · Executive Officer
  • Shaun R. Bagai · Executive Officer, Director
  • Kirsten Angela Macfarlane · Director
  • Laurence J. Marton · Director
  • Robert J. Spiegel · Director
  • Una S. Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • T.R. WINSTON & COMPANY, LLC (CRD 10571) · Bedminster, New JerseySold in all US states

Remarks in the notice

  • On the amounts: “The offering is closed.”

Signed by Shaun R. Bagai, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Apr 9, 2026. Read the notice at the SEC.

equity, optionsSEC
Apr 2024$11 MPrivate placement after listing$10 to $50 million

RenovoRx, Inc.: Private sale, Apr 2024

Investors in this round

172 investors had bought by the notice of Apr 22, 2024: 172 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $15 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$1,280,937
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Leesa B. Gentry · Executive Officer
  • Ramtin R. Agah · Executive Officer, Director
  • Ronald B. Kocak · Executive Officer
  • Shaun R. Bagai · Executive Officer, Director
  • Kirsten Angela Macfarlane · Director
  • Laurence J. Marton · Director
  • Robert S. Spiegel · Director
  • Una S. Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Newbridge Securities Corporation (CRD 104065) · Boca Raton, FloridaSold in all US states

Remarks in the notice

  • On the amounts: “The offering is closed.”

Signed by Shaun R. Bagai, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Apr 22, 2024. Read the notice at the SEC.

equity, optionsSEC
Jan 2024$6 MPrivate placement after listing$2 to $10 million

RenovoRx, Inc.: Private sale, Jan 2024

Investors in this round

92 investors had bought by the notice of Feb 9, 2024: 92 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $15 M offered; $9 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$508,043
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Angela Gill Nelms · Executive Officer
  • Ramtin R. Agah · Executive Officer, Director
  • Ron R. Kocak · Executive Officer
  • Shaun R. Bagai · Executive Officer, Director
  • Kirsten Angela Macfarlane · Director
  • Laurence J. Marton · Director
  • Robert S. Spiegel · Director
  • Una S. Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • PAULSON INVESTMENT COMPANY LLC (CRD 5670) · Portland, OregonSold in all US states

Signed by Shaun R. Bagai, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Feb 9, 2024. Read the notice at the SEC.

equitySEC
Apr 2018$8 MNo. 3$2 to $10 million

RenovoRx, Inc.: Raise no. 3, Apr 2018

Investors in this round

21 investors had bought by the notice of Jun 19, 2018: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $14 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series D Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kamran R. Najmabadi · Executive Officer
  • Ramtin R. Agah · Executive Officer, Director
  • Shaun R. Bagai · Executive Officer, Director
  • Laurence J. Marton · Director
  • Una S. Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Shaun Bagai, Chief Exec. Officer. Source: SEC Form D, newest notice filed Jun 19, 2018. Read the notice at the SEC.

equitySEC
Dec 2015$2 MNo. 2$2 to $10 million

RenovoRx, Inc.: Raise no. 2, Dec 2015

Investors in this round

18 investors had bought by the notice of Jan 5, 2016: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series C Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kamran R. Najmabadi · Executive Officer
  • Ramtin R. Agah · Executive Officer, Director
  • Shaun R. Bagai · Executive Officer, Director
  • Klaus R. Hambuechen · Director
  • Laurence J. Marton · Director
  • Una S. Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Shaun Bagai, Chief Exec. Officer. Source: SEC Form D, newest notice filed Jan 5, 2016. Read the notice at the SEC.

equitySEC
Dec 2013$1 MNo. 1Under $2 million

RenovoRx, Inc.: Raise no. 1, Dec 2013

Investors in this round

11 investors had bought by the notice of Dec 23, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
$25,000
What was sold
equity, other: Series B Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank S. Rahmani · Executive Officer
  • Kamran Gaia Najmabadi · Executive Officer
  • Marta Gaia Zanchi, Ph.D. · Executive Officer, Director
  • Klaus W. Hambuechen · Director
  • Laurence J. Marton, M.D. · Director
  • Ramtin Gaia Agah, M.D. · Director
  • Una S. Ryan, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Marta Gaia Zanchi, Ceo. Source: SEC Form D, newest notice filed Dec 23, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company RenovoRx, Inc., its revenue in fiscal 2025 came from these business segments: Other Operating $1.12 million (100%).

    Annual report (SEC XBRL) · Dec 2025

  • RenovoRx, Inc. had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Apr 2026).

    SEC Form D (revenue range) · Apr 2026

  • Revenue range over time, as stated in its notices: no revenue in 2024; revenue between $1 million and $5 million in 2026.

    SEC Form D (revenue range) · Apr 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2026

Products and services#

No products or services of RenovoRx, Inc. are on record.

Investors#

No investor of RenovoRx, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 21 investors.

Largest shareholders today

Institutions holding RenovoRx, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by RenovoRx, Inc.
NameRoleNamed in
Leesa R. GentryExecutive officerApr 2026
Mark R. VollExecutive officerApr 2026
Ramtin R. AgahExecutive officerApr 2026
Shaun R. BagaiExecutive officerApr 2026
Leesa B. GentryExecutive officerApr 2024
Ronald B. KocakExecutive officerApr 2024
Angela Gill NelmsExecutive officerFeb 2024
Ron R. KocakExecutive officerFeb 2024
Kamran R. NajmabadiExecutive officerJun 2018
Frank S. RahmaniExecutive officerDec 2013
Kamran Gaia NajmabadiExecutive officerDec 2013
Marta Gaia Zanchi, Ph.D.Executive officerDec 2013
Kirsten Angela MacfarlaneDirectorApr 2026
Laurence J. MartonDirectorApr 2026
Robert J. SpiegelDirectorApr 2026
Shaun R. BagaiDirectorApr 2026
Una S. RyanDirectorApr 2026
Ramtin R. AgahDirectorApr 2024
Robert S. SpiegelDirectorApr 2024
Klaus R. HambuechenDirectorJan 2016
Klaus W. HambuechenDirectorDec 2013
Laurence J. Marton, M.D.DirectorDec 2013
Marta Gaia Zanchi, Ph.D.DirectorDec 2013
Ramtin Gaia Agah, M.D.DirectorDec 2013
Una S. Ryan, Ph.D.DirectorDec 2013

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.